About IceCure Medical Ltd
https://www.icecure-medical.comIceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
CEO
Eyal Shamir
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2021-08-09 | Reverse | 1:8 |
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
TWO SIGMA SECURITIES, LLC
Shares:50.17K
Value:$34.3K
HRT FINANCIAL LP
Shares:46.7K
Value:$31.93K
GEODE CAPITAL MANAGEMENT, LLC
Shares:40.45K
Value:$27.66K
Summary
Showing Top 3 of 18
About IceCure Medical Ltd
https://www.icecure-medical.comIceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $850K ▲ | $18.2M ▲ | $-3.86M ▼ | -454% ▲ | $-0.06 ▼ | $-3.76M ▼ |
| Q2-2025 | $525K ▼ | $3.52M ▼ | $-3.36M ▲ | -640.76% ▼ | $-0.06 ▲ | $-3.32M ▲ |
| Q1-2025 | $725K ▼ | $3.88M ▼ | $-3.59M ▲ | -494.9% ▲ | $-0.06 ▲ | $-3.57M ▲ |
| Q4-2024 | $875K ▲ | $4.94M ▲ | $-4.48M ▼ | -511.89% ▲ | $-0.08 ▼ | $-4.44M ▼ |
| Q3-2024 | $662K | $4.53M | $-4.15M | -626.74% | $-0.08 | $-4.21M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $10.01M ▲ | $15.08M ▲ | $5.77M ▼ | $9.31M ▲ |
| Q2-2025 | $5.38M ▼ | $10.59M ▼ | $7.7M ▲ | $2.89M ▼ |
| Q1-2025 | $6.04M ▼ | $11.1M ▼ | $5.1M ▼ | $6M ▼ |
| Q4-2024 | $7.56M ▼ | $12.58M ▼ | $5.67M ▲ | $6.9M ▼ |
| Q3-2024 | $10.67M | $15.28M | $5.22M | $10.06M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-3.86M ▼ | $-2.71M ▲ | $-5M ▼ | $7.47M ▲ | $-412K ▲ | $-2.71M ▲ |
| Q2-2025 | $-3.36M ▲ | $-2.81M ▲ | $-23K ▼ | $2.08M ▼ | $-657K ▲ | $-2.83M ▲ |
| Q1-2025 | $-3.59M ▲ | $-4.04M ▲ | $-5K ▲ | $2.56M ▲ | $-1.52M ▲ | $-4.04M ▲ |
| Q4-2024 | $-4.48M ▼ | $-4.2M ▼ | $-7K ▼ | $1.1M ▼ | $-3.11M ▼ | $-4.2M ▼ |
| Q3-2024 | $-4.15M | $-3.15M | $805K | $3.36M | $1.02M | $-3.19M |
CEO
Eyal Shamir
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2021-08-09 | Reverse | 1:8 |
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
TWO SIGMA SECURITIES, LLC
Shares:50.17K
Value:$34.3K
HRT FINANCIAL LP
Shares:46.7K
Value:$31.93K
GEODE CAPITAL MANAGEMENT, LLC
Shares:40.45K
Value:$27.66K
Summary
Showing Top 3 of 18